Zipfel PF - Search Results

1

Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.

Strobel S, Hoyer PF, Mache CJ, Sulyok E, Liu WS, Richter H, Oppermann M, Zipfel PF, Józsi M. Strobel S, et al. Among authors: zipfel pf. Nephrol Dial Transplant. 2010 Jan;25(1):136-44. doi: 10.1093/ndt/gfp388. Epub 2009 Aug 7. Nephrol Dial Transplant. 2010. PMID: 19666655

2

Complement factor H and hemolytic uremic syndrome.

Zipfel PF, Skerka C, Caprioli J, Manuelian T, Neumann HH, Noris M, Remuzzi G. Zipfel PF, et al. Int Immunopharmacol. 2001 Mar;1(3):461-8. doi: 10.1016/s1567-5769(00)00047-3. Int Immunopharmacol. 2001. PMID: 11367530 Review.

3

Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?

Zipfel PF. Zipfel PF. Trends Immunol. 2001 Jul;22(7):345-8. doi: 10.1016/s1471-4906(01)01972-x. Trends Immunol. 2001. PMID: 11429311 Review.

4

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF. Manuelian T, et al. Among authors: zipfel pf. J Clin Invest. 2003 Apr;111(8):1181-90. doi: 10.1172/JCI16651. J Clin Invest. 2003. PMID: 12697737 Free PMC article.

5

Genetic screening in haemolytic uraemic syndrome.

Zipfel PF, Neumann HP, Józsi M. Zipfel PF, et al. Curr Opin Nephrol Hypertens. 2003 Nov;12(6):653-7. doi: 10.1097/00041552-200311000-00014. Curr Opin Nephrol Hypertens. 2003. PMID: 14564205 Review.

6

Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.

Józsi M, Manuelian T, Heinen S, Oppermann M, Zipfel PF. Józsi M, et al. Among authors: zipfel pf. Histol Histopathol. 2004 Jan;19(1):251-8. doi: 10.14670/HH-19.251. Histol Histopathol. 2004. PMID: 14702193 Review.

7

FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene.

Józsi M, Richter H, Löschmann I, Skerka C, Buck F, Beisiegel U, Erdei A, Zipfel PF. Józsi M, et al. Among authors: zipfel pf. Eur J Hum Genet. 2005 Mar;13(3):321-9. doi: 10.1038/sj.ejhg.5201324. Eur J Hum Genet. 2005. PMID: 15562282

8

Complement and diseases: defective alternative pathway control results in kidney and eye diseases.

Zipfel PF, Heinen S, Józsi M, Skerka C. Zipfel PF, et al. Mol Immunol. 2006 Jan;43(1-2):97-106. doi: 10.1016/j.molimm.2005.06.015. Mol Immunol. 2006. PMID: 16026839 Review.

9

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

Jokiranta TS, Cheng ZZ, Seeberger H, Jòzsi M, Heinen S, Noris M, Remuzzi G, Ormsby R, Gordon DL, Meri S, Hellwage J, Zipfel PF. Jokiranta TS, et al. Among authors: zipfel pf. Am J Pathol. 2005 Oct;167(4):1173-81. doi: 10.1016/S0002-9440(10)61205-9. Am J Pathol. 2005. PMID: 16192651 Free PMC article.

10

Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.

Józsi M, Heinen S, Hartmann A, Ostrowicz CW, Hälbich S, Richter H, Kunert A, Licht C, Saunders RE, Perkins SJ, Zipfel PF, Skerka C. Józsi M, et al. Among authors: zipfel pf. J Am Soc Nephrol. 2006 Jan;17(1):170-7. doi: 10.1681/ASN.2005080868. Epub 2005 Dec 7. J Am Soc Nephrol. 2006. PMID: 16338962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters